Voclosporin denied as not medically necessary by Aetna?

Aetna's specific coverage criteria for voclosporin are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies Voclosporin on Medical-Necessity Grounds

Voclosporin is an FDA-approved calcineurin inhibitor indicated for adults with active lupus nephritis (LN), used in combination with a background immunosuppressive regimen. Aetna's medical-necessity denials typically reflect one of three concerns: the diagnosis of active LN has not been sufficiently documented in the submitted record, the required background therapy is not clearly identified, or the clinical severity criteria in Aetna's own coverage policy are not demonstrably met.

These denials are routinely reversed on appeal — the bar is documentation completeness, not clinical eligibility itself.

## Your Appeal Rights

• Internal appeal: You have the right to a full-and-fair review under ERISA §503 (employer-sponsored plans) or applicable state law (individual/marketplace plans). Submit within the plan's stated deadline (commonly 180 days of the denial).
• External review: Under ACA §2719, if the internal appeal fails you may request an independent external review by an accredited IRO. The external-review request window is typically four months from the final internal denial. An external reviewer's decision is binding on Aetna.
• Expedited review: If your condition is urgent or you are currently hospitalized, request expedited internal and external review simultaneously — decisions are required within days, not weeks.

## Documentation to Gather

1. Diagnosis confirmation — kidney biopsy pathology report confirming lupus nephritis and its class; treating nephrologist's or rheumatologist's clinical notes establishing active disease. 2. Disease activity — laboratory reports and clinical assessments documenting proteinuria and renal function trends over time (no specific numbers required in your letter — just supply the actual records). 3. Prior treatment history — a dated list of every immunosuppressive agent tried, with start/stop dates and documented reasons for discontinuation or inadequate response. 4. Background regimen confirmation — documentation that the prescribed background immunosuppressive therapy is in place, consistent with the FDA-approved voclosporin labeling. 5. Medical-necessity letter — a detailed letter from the prescribing nephrologist/rheumatologist stating why voclosporin is medically necessary for this patient, referencing the applicable guideline organizations (e.g., ACR, KDIGO) without asserting specific numbers.

## Criteria-Mapping Structure

Obtain Aetna's published Clinical Policy Bulletin for voclosporin and the FDA-approved prescribing label. Then build a two-column table:

| Policy / Label Requirement | Supporting Chart Evidence | |---|---| | Diagnosis of active lupus nephritis | [Biopsy date, class, treating physician note] | | Use with specified background therapy | [Prescription records, pharmacy fill history] | | Patient age / indication match | [Demographics, diagnosis codes] | | Any additional Aetna-specific criterion | [Exact chart entry that satisfies it] |

Present this table in your appeal letter so the reviewer can check each box without searching the record. Completeness — not clinical argument — wins most medical-necessity reversals at Aetna.